Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Migraine With AuraMigraine Without Aura
Interventions
DRUG

Dronabinol MDI

Trial Locations (29)

Unknown

Site 10, Huntsville

Site 8, Huntsville

Site 11, Tucson

Site 3, Anaheim

Site 6, San Francisco

Site 15, Stockton

Site 26, Melbourne

Site 22, New Port Richey

Site 18, Orange City

Site 27, Pembroke Pines

Site 14, Plantation

Site 24, Plantation

Site 7, St. Petersburg

Site 25, Atlanta

Site 12, Chicago

Site 1, Chicago

Site 28, Lexington

Site 20, Madisonville

Site 2, Boston

Site 19, Omaha

Site 29, Clementon

Site 4, Mount Vernon

Site 9, Raleigh

Site 23, Fargo

Site 13, Portland

Site 5, Spartanburg

Site 16, Bryan

Site 17, Colleyville

Site 21, Alexandria

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nektar Therapeutics

INDUSTRY

lead

Solvay Pharmaceuticals

INDUSTRY